Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial

INTRODUCTION: Pancreatic cancer is the fourth-leading cause of cancer-related death in developed countries. Despite advances in systemic chemotherapy, the mainstay of curative therapy for non-metastatic disease is surgical resection. However, the perioperative period is characterised by stress and i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Open
Main Authors: Hüttner, Felix J, Rooman, Ilse, Bouche, Gauthier, Knebel, Phillip, Hüsing, Johannes, Mihaljevic, André L, Hackert, Thilo, Strobel, Oliver, Büchler, Markus W, Diener, Markus K
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7528424/
https://ncbi.nlm.nih.gov/pubmed/32998931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-040406
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki